Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
María‐Victoria Mateos(Complejo Hospitalario de Salamanca), Hilary Blacklock(Middlemore Hospital), Fredrik Schjesvold(University of Oslo), Albert Oriol(Institut Català d'Oncologia), David Simpson(North Shore Hospital), Anupkumar George(Wellington Hospital), Hartmut Goldschmidt(National Center for Tumor Diseases), Alessandra Larocca(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Asher Chanan‐Khan(Mayo Clinic in Florida), Daniel W. Sherbenou(University of Colorado Cancer Center), Irit Avivi(Tel Aviv Sourasky Medical Center), Noam Benyamini(Rambam Health Care Campus), Shinsuke Iida(Mizuho (Japan)), Morio Matsumoto(National Hospital Organization), Kenshi Suzuki(Japanese Red Cross Society, Japan), Vincent Ribrag(Institut Gustave Roussy), Saad Z. Usmani(Levine Cancer Institute), Sundar Jagannath(Mount Sinai Hospital), Enrique M. Ocio(Universidad de Cantabria), Paula Rodríguez‐Otero(Clinica Universidad de Navarra), Jesús F. San Miguel(Clinica Universidad de Navarra), Uma Kher(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mohammed Z.H. Farooqui(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jason J. Z. Liao(Merck & Co., Inc., Rahway, NJ, USA (United States)), Patricia Marinello(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sagar Lonial(Emory University), Andrew J. Nicol, George Grigoriadis(Wellington Hospital), John Catalano, Richard LeBlanc, Mohamed Elemary, Nizar J. Bahlis, Thierry Façon, Lionel Karlin, Vincent Ribrag(Institut Gustave Roussy), Michel Attal, Hartmut Goldschmidt(Heidelberg University), Monika Engelhardt, Katja Weisel, Andréas Mackensen, Arnon Nagler, Dina Ben Yehuda, Irit Avivi(Tel Aviv Sourasky Medical Center), Noam Benyamini(Rambam Health Care Campus), Hila Magen‐Nativ(Middlemore Hospital), Antonio Palumbo, Michèle Cavo, Kensei Tobinai, Shinsuke Iida(Nagoya City University), Takaai Chou, Kenshi Suzuki(Japanese Red Cross Society, Japan), Hiroshi Kosugi, Masafumi Taniwaki, Kazutaka Sunami, Morio Matsumoto(National Hospital Organization), Kiyoshi Ando, Peter Ganly, Hilary Blacklock(Middlemore Hospital), David Simpson(North Shore Hospital), Anupkumar George(Wellington Hospital), Fredrik Schjesvold(Oslo University Hospital), Bjørn Tore Gjertsen, Juan José Lahuerta, Joan Bladé, Albert Oriol Rocafiguera(Institut Català d'Oncologia), María‐Victoria Mateos(Instituto de Investigación Biomédica de Salamanca), Paula Rodríguez‐Otero(Centro de Investigación Biomédica en Red de Cáncer), Sarah M. Larson, Djordje Atanackovic, Srinivas Devarakonda, Jacob D. Bitran, Jeffrey A. Zonder, Neil Morganstein, Mohammad Hay, Asher Chanan‐Khan(Mayo Clinic in Florida), Gene Saylors, Ebenezer A. Kio, Ira Oliff, Dean Kirkel, Mikhail Shtivelband, Carrie Yuen, Andrew J. Yee, Jatin J. Shah, Myo Htut, Shahzad Raza, Saurabh Chhabra, Patrick J. Stiff, Parameswaran Hari, Bruce Bank, Ehsan Malek, Cristina Gasparetto, Ycaoub Faroun, Daniel W. Sherbenou(University of Colorado Cancer Center), William Kreisle, Seema Singhal, Jacalyn Rosenblatt, Saad Z. Usmani(Levine Cancer Institute), Wes Lee, Hana Safah(Mayo Clinic in Florida), Jose Lutzky, Jason Suh(Merck & Co., Inc., Rahway, NJ, USA (United States)), Dorothy W. Pan, Ari David Baron(Merck & Co., Inc., Rahway, NJ, USA (United States)), Robert Manges, Ronald G. Steis, Moacyr Oliveira, Jan S. Moreb, Natalie S. Callander, Bertrand Anz, Anastasios Raptis, Laura Stampleman, Jason M. Melear(Merck & Co., Inc., Rahway, NJ, USA (United States)), Thomas E. Boyd, Lawrence Garbo, Leonard M. Klein, Spencer H. Shao, Roger M. Lyons, Kristi McIntyre, Stefano Tarantolo, Christopher A. Yasenchak, Habte Yimer
Cited by 251Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis